Tag: insightec

[Insightec in PR Newswire] Insightec announces milestone of first patients enrolled in the pivotal LIBERATE clinical trial (Liquid Biopsy with Low Intensity Ultrasound in Brain Tumors)

HAIFA, Israel & MIAMI, Dec. 15, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, announced today the first patients have enrolled in the pivotal LIBERATE clinical trial (Liquid Biopsy with Low Intensity Ultrasound in Brain Tumors). Enrollment in LIBERATE marks the start of an international effort to assess safety and efficacy of using Insightec’s focused ultrasound (FUS) platform to temporarily disrupt the blood brain barrier (BBB) to enable liquid biopsies in patients with glioblastoma, the most common primary malignant brain tumor in adults. Read...

Read More

[Insightec in PR Newswire] Insightec’s focused ultrasound for essential tremor study results demonstrated sustained and significant tremor improvement maintained out to 5 years

HAIFA, Israel and MIAMI, Nov. 7, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced the publication of the largest prospective, long-term follow-up study of unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor to date. Read...

Read More

[Insightec in Business Wire] SonALAsense forges ahead with first patient dosing for devastating childhood brain cancer

OAKLAND, Calif.–(BUSINESS WIRE)–Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly pediatric brain cancer with a 2% five-year survival rate. To provide therapeutic options for patients and families, SonALAsense is partnering with clinicians at Children’s National Hospital, Ivy Brain Tumor Center at Barrow Neurological Institute, Phoenix Children’s Hospital and University of California San Francisco (UCSF) Medical Center to conduct a phase 1/2 clinical trial for sonodynamic therapy (SDT). This is the first SDT trial for children. Read...

Read More

[Insightec in PR Newswire] Insightec announces financing up to $200 million to fund continued growth

HAIFA, Israel and MIAMI, Sep. 1, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it signed a credit facility for up to $200 million with affiliates of existing shareholders Perceptive Advisors and Community Fund. The financing has provided Insightec with $100 million at closing, with an additional $100 million of financing potentially available in tranches through 2024. The credit facility is interest-only for five years and matures on August 31, 2027. Read...

Read More

Latest from Twitter